ARC Medical Inc.
About ARC Medical Inc.
ARC Medical Inc. is a leader in surgical adhesion prevention developing high-molecular-weight, polymer-based liquid adhesion barrier medical devices. The company’s JOCOAT™ and IPCOAT™ products are in clinical development for the prevention of orthopedic and gynecological & abdominal surgical adhesions respectively. ARC improves surgical patient recovery by preventing internal adhesions and operates ISO 13485:2016 and cGMP-aligned quality systems while holding a multi-family patent portfolio.
- 🔗 ARC Completes USD $3 Million Financing - ARC Medical Inc.
- 🔗 ARC Medical - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 ARC Medical Inc. Completes USD $3 Million Financing to Advance Surgical Adhesion Clinical Trials | ARC Medical Inc. | 15 comments
- 🔗 ARC Medical - 2026 Funding Rounds & List of Investors - Tracxn
- 🔗 ARC Medical, Inc. | MTEC
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed USD $3 million financing to advance clinical trials
- Developing JOCOAT™ and IPCOAT™ liquid adhesion barrier devices
- First clinical deployments completed in knee and shoulder patients after Phase 1 safety trial
- Holds multi-family patent portfolio and pursues commercialization partnerships
Ask StreetZero about ARC Medical Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account